Beijing Kawin Technology Share-Holding Co., Ltd. (SHA:688687)

Market Cap	4.89B
Revenue (ttm)	1.20B
Net Income (ttm)	147.35M
Shares Out	167.44M
EPS (ttm)	0.88
PE Ratio	33.13
Forward PE	30.29
Dividend	0.30 (1.04%)
Ex-Dividend Date	Jun 11, 2025

Volume	5,983,102
Average Volume	6,241,284
Open	29.00
Previous Close	28.91
Day's Range	28.50 - 29.55
52-Week Range	20.70 - 40.19
Beta	0.93
RSI	44.69
Earnings Date	Oct 22, 2025

About SHA:688687

Beijing Kawin Technology Share-Holding Co., Ltd., a biopharmaceutical company, provides treatment solutions for viral and immune diseases in China. The company’s products include recombinant human interferon alfa-2b injection; interferon alfa-2b vaginal effervescent tablets; coblopasvir hydrocholoride capsules; sofosbuvir tablets; peginterferon Alfacon-2 Injection; and compound glycyrrhizin tablets, capsules, and injections, as well as pirfenidone tablets. The company was founded in 2008 and is based in Beijing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 600
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688687

Financial Performance

In 2024, SHA:688687's revenue was 1.23 billion, a decrease of -12.87% compared to the previous year's 1.41 billion. Earnings were 142.37 million, an increase of 22.18%.